Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I never found it very settling to watch companies buy back shares, or reverse split shares. Then down the road create more shares for a project.
Graduating to a new exchange is an old school excuse. Sometimes good and sometimes bad for the shareholder. My opinion is to sell prior to a reverse split, as so many times I have seen failure, but then that is generally when a company is threatened to being delisted.
So what does an individual investor do? Watch and reason in my opinion.
Then dilute the shares to raise cash? That is a possibility.
Gardner Denver Holdings, Inc. (GDI). Excellent earnings. The conference call is actually uniquely interesting. I think you would all be impressed with today's conference call replay when available. The replay will be available online at https://www.investornetwork.com/company/60657.
I own a small amount of shares.
Opinion shared.
Why 8x8, Inc. Shares Fell 12.7% in July
The company is betting the farm on large-scale enterprise customers. Forget the short-term earnings torpedoes and full speed ahead.
Anders Bylund (TMFZahrim)
Aug 1, 2017 at 4:20PM
What happened
Shares of cloud-based communications expert 8x8 (NASDAQ:EGHT) fell 12.7% in July 2017, according to data from S&P Global Market Intelligence.
So what
The main culprit behind 8x8's rough July came at the very end of the month, in the form of a mixed earnings report. The first quarter of fiscal year 2018 saw 8x8's earnings fall by 66% year over year to $0.02 per share while sales increased 15% to land at $69.1 million. Analysts were looking for earnings of $0.03 per share but would have settled for $68.6 million in top-line revenues. Planning ahead, management reiterated 8x8's full-year revenue guidance of approximately $298 million but lowered its pre-tax profit targets from $24 million to $9 million.
The following day, share prices fell as much as 30% on the news before climbing back to a less drastic 12% drop. All told, 9x9 shares have now lost 7% of their value over the last 52 weeks.
Now what
It's true that 8x8's profits are suffering right now, but you could also argue that it's for all the right reasons. The company had an opportunity to pocket a small windfall in the first quarter and continue doing so over the next couple of reporting periods, but management chose to double down on engineering and marketing for the wide-open enterprise class of cloud-based voice communications.
I called this drop a buy-in opportunity last week, and I stand by that call today. 8X8's stock may look expensive right now, but that looks like a temporary trick of the light and a solid buying window.
Conference call and other events link http://investors.8x8.com/events.cfm
Rudolph Concludes Patent Infringement Lawsuit Against Camtek
[Business Wire]
Business WireJuly 31, 2017
https://finance.yahoo.com/news/rudolph-concludes-patent-infringement-lawsuit-103000620.html
WILMINGTON, Mass.--(BUSINESS WIRE)--
Rudolph Technologies, Inc. (RTEC), a leading provider of process characterization equipment, lithography equipment and software for wafer fabs and advanced packaging facilities, announced today that it has reached a comprehensive patent settlement with Camtek, Ltd. in the ongoing patent infringement lawsuits between the two companies. Under the terms of the settlement agreement, the parties will dismiss all current litigation matters and Camtek will pay to Rudolph a one-time payment of $13 million. The parties have also entered into a covenant not to sue one another related to the three patents at issue in the lawsuits and also not to sue one another for any cause of action for a period of three years anywhere in the world.
“This agreement brings to a close the long-running dispute between Rudolph and Camtek relating to Rudolph’s patents on semiconductor inspection technology,” said Robert Koch, vice president and general counsel for Rudolph. “We are gratified to close this chapter as we continue to focus on innovative disruptive technologies that enable a smarter, more connected world.”
The dispute over patent infringement began in 2005 and has included multiple claims of misappropriation of Rudolph’s proprietary, patented technology as well as violations of an injunction on sales of certain Camtek products. In 2016, a Federal Court of Appeals confirmed a lower court’s favorable judgement related to the initial lawsuit between the companies and awarded Rudolph damages in excess of $14.5 million. The present settlement resolves each of the remaining lawsuits currently pending.
For more information about Rudolph’s systems and software, please visit www.rudolphtech.com.
About Rudolph Technologies
Rudolph Technologies, Inc. is a leader in the design, development, manufacture and support of defect inspection, lithography, process control metrology, and process control software used by semiconductor and advanced packaging device manufacturers worldwide. Rudolph delivers comprehensive solutions throughout the fab with its families of proprietary products that provide critical yield-enhancing information, enabling microelectronic device manufacturers to drive down costs and time to market of their devices. Headquartered in Wilmington, Massachusetts, Rudolph supports its customers with a worldwide sales and service organization. Additional information can be found on the Company’s website at www.rudolphtech.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”) related to the protection of its intellectual property as well as other matters that are not purely historical data. Rudolph wishes to take advantage of the “safe harbor” provided for by the Act and cautions that actual results may differ materially from those projected as a result of various factors, including risks and uncertainties, many of which are beyond Rudolph’s control. Such factors include, but are not limited to, results of future litigation and the challenges presented related to the enforcement of its patents. Additional information and considerations regarding the risks faced by Rudolph are available in Rudolph’s Form 10-K report for the year ended December 31, 2016 and other filings with the Securities and Exchange Commission. As the forward-looking statements are based on Rudolph’s current expectations, the company cannot guarantee any related future results, levels of activity, performance or achievements. Rudolph does not assume any obligation to update the forward-looking information contained in this press release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170731005321/en/
I do not think that the expected forward thinking outlook of the CEO, even though the CEO has time and time again proven the business plan continues to work found favor with some of the investment community. The momentum is not stopping, either is the revenue, just a temporary adjustment in operating expenses to evolve the company into a bigger revenue maker.
"We are therefore adjusting our fiscal 2018 non-GAAP pre-tax income guidance from a previously announced range of approximately 7% to 9% of revenue to approximately 3% of revenue, while maintaining our revenue guidance. This increased investment will allow us to accelerate future growth and continue to drive attractive shareholder returns.”
The first part, the adjustment, is what was read and learned, all the while missing the second part future growth.
So I expect that 8x8 will once again have to prove it meaning the future growth.
OPINION
In my opinion you will be out of your daily hobby job on this message board when the "PTSC OUT OF BUSINESS" signs go up.
If you had paid a attention of some of my previous message posts. You would know I have not owned any PTSC for a very long time. But I will not call you lazy for not doing so.
I looked up the share price for you to help you start your day $0.0141
Hope this helps.
Defining what order he is actually speaking about. Order granted for withdrawal? Got me lost!
Well MNGA is in the start of another 30 consecutive business days having a closing price below the minimum $1.00 share requirement for continued listing. Then MNGA will get a delisting notice.
Nasdaq's Listing Rule 5550(a)(2) (the "Rule")
Most likely if that does happen the company will file requesting a 180 calendar day extension.
Nasdaq's Listing Rule 5810(c)(3)(A)
OPINION ONLY
'Order Granted" please define the meaning of the order.
Great news release with some revenue meaning. One way to get this stock healed. It's a start. I wonder how much it was costing MNGA to fund the developmental project in Italy? I trust that the research and development monies might be saved going forward. That is a question I do not have an answer to presently.
I see the stock is down again today on news.
I still do not own any shares.
Opinion.
Still pathetic, but healing takes time, that is if it can be healed.
Almost sounds to good to be true. A true preventative for the common flu.
None-the-less, a phase 2 has succeeded.
:)
I hate the flu.
RTEC and EGHT are both buy out candidates.
RTEC is likely to be part of the ongoing semi conductor sector consolidation.
https://ih.advfn.com/stock-market/NYSE/rudolph-technologies-inc-RTEC/stock-price
EGHT is now at servicing Enterprise level customers. EGHT has itself up for sale. Telecommunications is also another hot sector for consolidation.
https://ih.advfn.com/stock-market/NASDAQ/8x8-mm-EGHT/stock-price
GDI already graded at $26 a share initially after launching their IPO.
Earnings are to be presented August 2nd. I would expect possibly another upgrade. Of course that is my opinion only.
Gardner Denver Holdings, Inc. GDI
https://ih.advfn.com/stock-market/NYSE/gardner-denver-GDI/stock-price
http://investors.gardnerdenver.com/
$26 a share. I would expect an upgrade August 2 when the financials are presented. Of course that is my opinion.
Retail sellers, not institutions selling. The bottom line is TXMD is still alive. FDA wants to review the new information. More wait and see unfortunately.
It just does not seem ethical about the way the FDA releases information. If they drag the release of the minutes summary to after hours on a Friday night.
They really need to make a rule that all releases by the FDA be no later than 1:00PM. They just have to know what this does to a company and its' shareholders. Hurry up and wait has got to stop.
Do or die for TXMD. Waiting on the outcome of the FDA meeting minutes. The general due date is sometime today which is 30 days since the meeting. Most figure a black box label will be required until a phase 4 clinical 12 month study is submitted. Only a 30 day study was presented on endometrial reaction which had no reaction and had followed the guidelines of the FDA, but the FDA initially objected because of that reason.
TXMD holding on my pocket change play as previously posted.
https://finance.yahoo.com/quote/TXMD?ltr=1
My opinion the share price should easily be in the $90's if not a $100, just based on the yield alone in comparison to many other stocks. DUK could be considered a bargain. Besides the strong growth and repeated earnings prove DUK as a strong stock.
But that is my sole opinion only.
Simple is best and it is also honest.
So they can reorganize and ruin more investor lives.
Joking of course, but it is the American way.
It still surviving at $0.0175
Well are you not the picky one. lol! I assume that is another project we will need to fix going forward.
The board has been changed to ALO thanks to Admin Shelly
We can just no body has contacted ADMIN. I will do it if you like
$0.40 pre split = $4 a share in comparison presently.
So where is bottom? Is this bottom and or near it?
Watching.
The financing is a done deal. The chart showing a downward direction.
You are correct about the major potential. That is obvious. The problem is the financials at the moment, and a recent reverse split which must of stained the investor trust platform even more. Now the company is only $0.21 from another delisting notice, as the share price keeps folding backwards.
Recently the company has actually taken meaningful steps in rolling in the cash burn ratio which was enormously out of line. I am assuming the next 6 months of financials will tell how effective those financial cutbacks have been. If effective then I just might give these shares another chance.
I do not want to mislead anyone in giving reassurances going forward. I like this company, but it does not mean it is a good investment because I like it. Financially this company is way behind itself from showing some profit on the books.
Wait and see is my best offer for the moment. I also do not own shares for the moment.
My best and good luck investing.
DUKE is gold in my opinion.
The safety trial will not meet the life expectancy of the end product. So in other words I do not know what would be the FDA's disapproval cause. I would imagine a stage 4 trial, as a condition of approval.
On a very erratic and generalized population figure of 7.7 billion.
I figure it will take 192 years by the annualized bulk production number to vaccinate all of the world population.
Then I ask who is going to pay for all of those people? Most pharmaceuticals are sold for exorbitant prices in the United States.
SOX showing life. The trend of the semi-conductor consolidation has a lot of room to merge in my opinion. I use the SOX as a trend signal only.
PHLX Semiconductor (^SOX) showing a good swing upward from morning to afternoon. I think the one month chart shows it has based. Of course it could well take a downward direction, but I have three bounces off this one month chart at this level to offer credibility.
I only presented this tid bit finding for those who might find interest in the selective semi conductor stocks or as a group.
Now to look over the group.
MY opinion.
I did add it some time ago through your efforts to my watch list group. The company in regards to share holder reward has a long ways to go in my opinion. Not saying the company is bad. I am saying they are still developing their agreements into productive projects.
I do like the the basics of the company for what one day it may offer productive products to market.
When is the market going to have the foresight to see that the transportation and other is going alternate energy despite Donald Trump?
RTEC - Rudolph Tech. 10% is big in tech. News is big.
"Moving from round wafers to rectangular panels saves corner space, delivering a roughly ten-percent improvement in surface utilization. "
and another associated article
http://www.nasdaq.com/press-release/rudolph-jetstep-s-lithography-system-advances-panelbased-advanced-packaging-20170523-00243